AUGUSTA, Ga.— AUGUSTa Pharmaceuticals Inc. (NASDAQ:UGPS), a leading supplier of pharmaceutical engineering and pharmaceuticals to the pharmaceutical and health care industries, has been boosted 2.5% in value to $1.5 billion after the company reported earnings Thursday that increased earnings per share by 2.2% over the previous quarter.The company also reported that its clinical-stage drug-delivery platform […]

Continue Reading...